Birkeland, E., Busch, C., Berge, E. O., Geisler, J., Jönsson, G., Lillehaug, J. R., . . . Lønning, P. E. (2013). Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma. Springer Netherlands.
シカゴスタイル引用形Birkeland, Einar, Christian Busch, Elisabet Ognedal Berge, Jürgen Geisler, Göran Jönsson, Johan Richard Lillehaug, Stian Knappskog, , Per Eystein Lønning. Low BRAF and NRAS Expression Levels Are Associated With Clinical Benefit From DTIC Therapy and Prognosis in Metastatic Melanoma. Springer Netherlands, 2013.
MLA引用形式Birkeland, Einar, et al. Low BRAF and NRAS Expression Levels Are Associated With Clinical Benefit From DTIC Therapy and Prognosis in Metastatic Melanoma. Springer Netherlands, 2013.